| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group Lancet (London, England) 397 (10285), 1637, 2021 | 1650 | 2021 |
| Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort DE Shaw, AR Sousa, SJ Fowler, LJ Fleming, G Roberts, J Corfield, ... European Respiratory Journal 46 (5), 1308-1321, 2015 | 627 | 2015 |
| A European Respiratory Society technical standard: exhaled biomarkers in lung disease I Horváth, PJ Barnes, S Loukides, PJ Sterk, M Högman, AC Olin, A Amann, ... European Respiratory Journal 49 (4), 2017 | 587 | 2017 |
| Dysfunctional breathing: a review of the literature and proposal for classification R Boulding, R Stacey, R Niven, SJ Fowler European Respiratory Review 25 (141), 287-294, 2016 | 359 | 2016 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10289), 2049, 2021 | 342 | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group Lancet (London, England) 397 (10274), 605, 2021 | 339 | 2021 |
| U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics D Lefaudeux, B De Meulder, MJ Loza, N Peffer, A Rowe, F Baribaud, ... Journal of Allergy and Clinical Immunology 139 (6), 1797-1807, 2017 | 314 | 2017 |
| Application of’omics technologies to biomarker discovery in inflammatory lung diseases CE Wheelock, VM Goss, D Balgoma, B Nicholas, J Brandsma, PJ Skipp, ... European Respiratory Journal 42 (3), 802-825, 2013 | 312 | 2013 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 288 | 2022 |
| Exhaled breath analysis: a review of ‘breath-taking’methods for off-line analysis O Lawal, WM Ahmed, TME Nijsen, R Goodacre, SJ Fowler Metabolomics 13 (10), 1-16, 2017 | 284 | 2017 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial J Chalmers, H Abo-Leyah, H Loftus, M Spears, ... Lancet 397 (10285), 1637-1645, 2021 | 270 | 2021 |
| The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts L Fleming, C Murray, AT Bansal, S Hashimoto, H Bisgaard, A Bush, ... European Respiratory Journal 46 (5), 1322-1333, 2015 | 254 | 2015 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... MedRxiv, 2021.06. 15.21258542, 2021 | 249 | 2021 |
| Non-invasive phenotyping using exhaled volatile organic compounds in asthma B Ibrahim, M Basanta, P Cadden, D Singh, D Douce, A Woodcock, ... Thorax 66 (9), 804-809, 2011 | 237 | 2011 |
| Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial SAFC Mitchell, R Garrod, L Clark, A Douiri, SM Parker, J Ellis, SJ Fowler, ... Thorax 72 (2), 129-136, 2017 | 221 | 2017 |
| Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics SJ Fowler, J French, NJ Screaton, J Foweraker, A Condliffe, CS Haworth, ... European Respiratory Journal 28 (6), 1204-1210, 2006 | 205 | 2006 |
| A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED CHS Kuo, S Pavlidis, M Loza, F Baribaud, A Rowe, I Pandis, U Hoda, ... American Journal of Respiratory And Critical Care Medicine, 2016 | 198 | 2016 |
| Taking your breath away: metabolomics breathes life in to personalized medicine NJW Rattray, Z Hamrang, DK Trivedi, R Goodacre, SJ Fowler Trends in biotechnology 32 (10), 538-548, 2014 | 182 | 2014 |
| Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation Z Jevnikar, J Östling, E Ax, J Calvén, K Thörn, E Israelsson, L Öberg, ... Journal of Allergy and Clinical Immunology 143 (2), 577-590, 2019 | 172 | 2019 |
| “T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin S Pavlidis, K Takahashi, FNK Kwong, J Xie, U Hoda, K Sun, ... European Respiratory Journal 53 (1), 2019 | 166 | 2019 |
Kian Fan ChungImperial College LondonBestätigte E-Mail-Adresse bei imperial.ac.uk